Evidence map›Paper›PMID 35211423›Full record

ReviewFrontiers in cellular and infection microbiology2022

SARS-CoV-2: The Monster Causes COVID-19.

Chang Song, Zesong Li, Chen Li, Meiying Huang, Jianhong Liu, Qiuping Fang, Zitong Cao, Lin Zhang, Pengbo Gao, Wendi Nie and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Systematic pan-cancer analysis identifiesAnnals of translational medicine · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Chang SongSchool of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China.
Zesong LiGuangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Department of Urology, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital (Shenzhen Institute of Translational Medicine), Shenzhen, China.
Chen LiDepartment of Biology, Chemistry, Pharmacy, Free University of Berlin, Berlin, Germany.
Meiying HuangZhu's Team, Guangdong Medical University, Zhanjiang, China.
Jianhong LiuZhu's Team, Guangdong Medical University, Zhanjiang, China.
Qiuping FangZhu's Team, Guangdong Medical University, Zhanjiang, China.
Zitong CaoZhu's Team, Guangdong Medical University, Zhanjiang, China.
Lin ZhangZhu's Team, Guangdong Medical University, Zhanjiang, China.
Pengbo GaoZhu's Team, Guangdong Medical University, Zhanjiang, China.
Wendi NieZhu's Team, Guangdong Medical University, Zhanjiang, China.
Xueyao LuoZhu's Team, Guangdong Medical University, Zhanjiang, China.
Jianhao KangZhu's Team, Guangdong Medical University, Zhanjiang, China.
Shimin XieZhu's Team, Guangdong Medical University, Zhanjiang, China.
Jianxin LyuSchool of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China.
Xiao ZhuSchool of Laboratory Medicine, Hangzhou Medical College, Hangzhou, China.
Guangdong Medical College · CNHangzhou Medical College · CNFreie Universität Berlin · DEShenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronaviruses are viruses whose particles look like crowns. SARS-CoV-2 is the seventh member of the human coronavirus family to cause COVID-19 which is regarded as a once-in-a-century pandemic worldwide. It holds has the characteristics of a pandemic, which has broy -55ught many serious negative impacts to human beings. It may take time for humans to fight the pandemic. In addition to humans, SARS-CoV-2 also infects animals such as cats. This review introduces the origins, structures, pathogenic mechanisms, characteristics of transmission, detection and diagnosis, evolution and variation of SARS-CoV-2. We summarized the clinical characteristics, the strategies for treatment and prevention of COVID-19, and analyzed the problems and challenges we face.

Indexed as

COVID-19AnimalsHumansPandemicsSARS-CoV-2COVID-19pandemicpreventionSARS-CoV-2therapy

Identifiers

PMID35211423
PMCPMC8861077
OpenAlexW4210921743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.